NEWS

NEWS TYPE
RELEASE YEAR

RESEARCH

[Publication] Neuromodulation by the immune system: implications for brain-directed immunotherapy

July 28, 2025

Co-authored by a Bio2Q researcher, this Review explores how the brain-immune axis acts as a key regulator of brain function and behavior through direct interactions with neural circuits. This work highlights how immunotherapies targeting neuroimmune pathways may offer therapeutic potential for psychiatric and neurological conditions.

Title Neuromodulation by the immune system: implications for brain-directed immunotherapy
Authors Daniel H Cho [1],[2], Jun R Huh [3], [4],[5], Gloria B Choi [1],[2]
Short Description This Review article, co-authored by a Bio2Q researcher, explores the growing recognition of the brain-immune axis as an important modulator of brain function and behavior, challenging the traditional view of the brain as immunologically isolated. This piece highlights how immune molecules, including cytokines and chemokines, influence neural activity, learning, memory, social behavior, and stress responses. The authors discuss the therapeutic potential of immunomodulatory approaches for neurological and psychiatric conditions, drawing on evidence from both animal models and clinical studies. This Review emphasizes recent findings that show immune signaling is a compelling target for brain-directed immunotherapy, and will provide a valuable resource that can be used to guide future research in neuroimmunology.
DOI https://doi.org/10.1016/j.coi.2025.102568.
Journal Current Opinion in Immunology
Vol/Num/Page Volume 95, 102568
Publication Date 2025年6月6日

Affiliations:
[1] Picower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA
[2] Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA
[3] Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA
[4] Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University, Tokyo, Japan
[5] Lurie Center for Autism, Massachusetts General Hospital, Lexington, MA, USA

More Bio2Q News

EVENT
2025.12.10

【12/12 Event】KEIO TECHNO-MALL 2025

The World Premier International Research Center (WPI) Keio University Human Biology-Microbiome-Quantum Research Center (Bio2Q) will exhibit ...

ANNOUNCEMENT
2025.12.09

WPI-Bio2Q now recruiting administrative staff– Deadline: January 12, 2026

WPI-Bio2Q Administrative Office is currently hiring administrative staff. We look forward to receiving applications from candidates with ...

EVENT
2025.12.08

The 4th Keio University WPI-Bio2Q International Symposium

The 4th Keio University WPI-Bio2Q International Symposium, entitled “Integration of Biology, Microbiome, and Metabolomics for Healthy Longev...

ANNOUNCEMENT
2025.12.08

COMPREHENSIVE SUPPORT FOR STARTING LIFE IN JAPAN

As part of our support for newcomers to Japan, Bio2Q has launched a welcome airport arrival assistance service under the Bio2Q Connect progr...

EVENT
2025.12.04

Inaugural Bio2Q "LEAD50" Lectureship Held

The 30th Keio Medical Science Prize Ceremony and Commemorative Lecture was held at the Kitasato Hall on Shinanomachi Campus on Tuesday, Nove...